Literature DB >> 27193218

Novel European SLC1A4 variant: infantile spasms and population ancestry analysis.

Judith Conroy1,2, Nicholas M Allen2,3, Kathleen Gorman2, Eoghan O'Halloran1, Amre Shahwan2, Bryan Lynch2, Sally A Lynch1, Sean Ennis1, Mary D King1,2.   

Abstract

SLC1A4 deficiency is a recently described neurodevelopmental disorder associated with microcephaly, global developmental delay, abnormal myelination, thin corpus callosum and seizures. It has been mainly reported in the Ashkenazi-Jewish population with affected individuals homozygous for the p.Glu256Lys variant. Exome sequencing performed in an Irish proband identified a novel homozygous nonsense SLC1A4 variant [p.Trp453*], confirming a second case of SLC1A4-associated infantile spasms. As this is the first European identified, population ancestry analysis of the Exome Aggregation Consortium database was performed to determine the wider ethnic background of SLC1A4 deficiency carriers. p.Glu256Lys was found in Hispanic and South Asian populations. Other potential disease-causing variants were also identified. Investigation for SLC1A4 deficiency should be performed regardless of ethnicity and extend to include unexplained early-onset epileptic encephalopathy.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27193218     DOI: 10.1038/jhg.2016.44

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  4 in total

1.  A homozygous mutation in SLC1A4 in siblings with severe intellectual disability and microcephaly.

Authors:  M Srour; F F Hamdan; Z Gan-Or; D Labuda; C Nassif; M Oskoui; M Gana-Weisz; A Orr-Urtreger; G A Rouleau; J L Michaud
Journal:  Clin Genet       Date:  2015-05-28       Impact factor: 4.438

2.  Mutations in SLC1A4, encoding the brain serine transporter, are associated with developmental delay, microcephaly and hypomyelination.

Authors:  Nadirah Damseh; Alexandre Simonin; Chaim Jalas; Joseph A Picoraro; Avraham Shaag; Megan T Cho; Barak Yaacov; Julie Neidich; Motee Al-Ashhab; Jane Juusola; Sherri Bale; Aida Telegrafi; Kyle Retterer; John G Pappas; Ellen Moran; Joshua Cappell; Kwame Anyane Yeboa; Bassam Abu-Libdeh; Matthias A Hediger; Wendy K Chung; Orly Elpeleg; Simon Edvardson
Journal:  J Med Genet       Date:  2015-06-03       Impact factor: 6.318

3.  SLC1A4 mutations cause a novel disorder of intellectual disability, progressive microcephaly, spasticity and thin corpus callosum.

Authors:  G Heimer; D Marek-Yagel; E Eyal; O Barel; D Oz Levi; C Hoffmann; E K Ruzzo; E Ganelin-Cohen; D Lancet; E Pras; G Rechavi; A Nissenkorn; Y Anikster; D B Goldstein; B Ben Zeev
Journal:  Clin Genet       Date:  2015-07-28       Impact factor: 4.438

4.  Na+ interactions with the neutral amino acid transporter ASCT1.

Authors:  Amanda J Scopelliti; Germano Heinzelmann; Serdar Kuyucak; Renae M Ryan; Robert J Vandenberg
Journal:  J Biol Chem       Date:  2014-05-07       Impact factor: 5.157

  4 in total
  6 in total

Review 1.  Functional and Biochemical Consequences of Disease Variants in Neurotransmitter Transporters: A Special Emphasis on Folding and Trafficking Deficits.

Authors:  Shreyas Bhat; Ali El-Kasaby; Michael Freissmuth; Sonja Sucic
Journal:  Pharmacol Ther       Date:  2020-12-10       Impact factor: 12.310

2.  A Novel SLC1A4 Mutation (p.Y191*) Causes Spastic Tetraplegia, Thin Corpus Callosum, and Progressive Microcephaly (SPATCCM) With Seizure Disorder.

Authors:  Hanadi A Abdelrahman; Aisha Al-Shamsi; Anne John; Bassam R Ali; Lihadh Al-Gazali
Journal:  Child Neurol Open       Date:  2019-10-08

Review 3.  Amino Acid Transport Defects in Human Inherited Metabolic Disorders.

Authors:  Raquel Yahyaoui; Javier Pérez-Frías
Journal:  Int J Mol Sci       Date:  2019-12-23       Impact factor: 5.923

Review 4.  West syndrome: a comprehensive review.

Authors:  Piero Pavone; Agata Polizzi; Simona Domenica Marino; Giovanni Corsello; Raffaele Falsaperla; Silvia Marino; Martino Ruggieri
Journal:  Neurol Sci       Date:  2020-08-22       Impact factor: 3.307

5.  Cerebrospinal fluid amino acids glycine, serine, and threonine in nonketotic hyperglycinemia.

Authors:  Michael A Swanson; Kristen Miller; Sarah P Young; Suhong Tong; Lina Ghaloul-Gonzalez; Juanita Neira-Fresneda; Lisa Schlichting; Cheryl Peck; Linda Gabel; Marisa W Friederich; Johan L K Van Hove
Journal:  J Inherit Metab Dis       Date:  2022-04-06       Impact factor: 4.750

6.  Comparative Proteome Research in a Zebrafish Model for Vanishing White Matter Disease.

Authors:  Doeun Kim; Yu-Ri Lee; Tae-Ik Choi; Se-Hee Kim; Hoon-Chul Kang; Cheol-Hee Kim; Sangkyu Lee
Journal:  Int J Mol Sci       Date:  2021-03-08       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.